ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 1 filers reported holding ACCELERON PHARMA INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $23,172,000 | +15.2% | 134,635 | -16.0% | 0.30% | +31.7% |
| Q2 2021 | $20,123,000 | -0.3% | 160,348 | +7.7% | 0.23% | -0.9% |
| Q1 2021 | $20,187,000 | +47.8% | 148,846 | +39.4% | 0.23% | +49.7% |
| Q4 2020 | $13,659,000 | +330.7% | 106,751 | +279.1% | 0.16% | +307.9% |
| Q3 2020 | $3,171,000 | +35.7% | 28,162 | +14.9% | 0.04% | +35.7% |
| Q2 2020 | $2,336,000 | +583.0% | 24,511 | +544.3% | 0.03% | +460.0% |
| Q1 2020 | $342,000 | – | 3,804 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Novo Holdings A/S | 1,103,937 | $53,563,000 | 5.39% |
| GREAT POINT PARTNERS LLC | 758,000 | $36,778,000 | 5.10% |
| Foresite Capital Management II, LLC | 244,756 | $11,876,000 | 4.18% |
| GREAT POINT PARTNERS LLC | 552,300 | $26,798,000 | 3.71% |
| Foresite Capital Management III, LLC | 278,753 | $13,525,000 | 2.91% |
| QVT Financial LP | 190,977 | $9,266,000 | 2.66% |
| Perceptive Advisors | 1,528,205 | $74,149,000 | 1.94% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,126,800 | $54,672,000 | 1.92% |
| SECTORAL ASSET MANAGEMENT INC | 306,626 | $14,877,000 | 1.66% |
| Parametrica Management Ltd | 5,645 | $274,000 | 1.30% |